Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer
Clinical trial NCT01363947 · COMPLETED
Trial details
- NCT number
- NCT01363947
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-14
- Primary completion
- 2016-06-03
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.